Genomic Interaction Profiles in Breast Cancer Reveal Altered Chromatin Architecture

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zeitz, Michael J ^a   Ay, Ferhat ^b   Heidmann, Julia D ^a   Lerner, Paula L ^a   Noble, William S ^b,c   Steelman, Brandon N ^a   Hoffman, Andrew R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RNA; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BCAS1 GENE; BCAS2 GENE; BCAS3 GENE; BCAS4 GENE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CHROMATIN; CHROMOSOME 1; CHROMOSOME 17; CHROMOSOME 20; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EGFR GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONTROL; GENE INTERACTION; HUMAN; HUMAN CELL; IGFBP3 GENE; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR GENE; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN; CHROMOSOME ABERRATIONS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84883315768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073974     Document Type: Article

References (66)

1. Misteli T, (2007) Beyond the sequence: cellular organization of genome function. Cell 128: 787-800.
2. Duan Z, Andronescu M, Schutz K, McIlwain S, Kim YJ, et al. (2010) A three-dimensional model of the yeast genome. Nature 465: 363-367.
3. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, et al. (2009) Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326: 289-293.
4. Noordermeer D, Leleu M, Splinter E, Rougemont J, De Laat W, et al. (2011) The dynamic architecture of Hox gene clusters. Science 334: 222-225.
5. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, et al. (2009) An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 462: 58-64.
6. Cope NF, Fraser P, Eskiw CH, (2010) The yin and yang of chromatin spatial organization. Genome biology 11: 204.
7. Ling JQ, Li T, Hu JF, Vu TH, Chen HL, et al. (2006) CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312: 269-272.
8. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA, (2005) Interchromosomal associations between alternatively expressed loci. Nature 435: 637-645.
9. Xu N, Tsai CL, Lee JT, (2006) Transient homologous chromosome pairing marks the onset of X inactivation. Science 311: 1149-1152.
10. Bacher CP, Guggiari M, Brors B, Augui S, Clerc P, et al. (2006) Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nature cell biology 8: 293-299.
11. Vu TH, Nguyen AH, Hoffman AR, (2010) Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Human molecular genetics 19: 901-919.
12. Shah SP, Roth A, Goya R, Oloumi A, Ha G, et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395-399.
13. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nature reviews Genetics 8: 286-298.
14. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, et al. (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
15. Meaburn KJ, Misteli T, (2008) Locus-specific and activity-independent gene repositioning during early tumorigenesis. The Journal of cell biology 180: 39-50.
16. Meaburn KJ, Gudla PR, Khan S, Lockett SJ, Misteli T, (2009) Disease-specific gene repositioning in breast cancer. The Journal of cell biology 187: 801-812.
17. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, et al. (1997) Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clinical cancer research: an official journal of the American Association for Cancer Research 3: 103-109.
18. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, et al. (1998) Insulin-like growth factor-binding protein-3 and breast cancer survival. International journal of cancer Journal international du cancer 79: 624-628.
19. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K, (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. International journal of cancer Journal international du cancer 111: 293-297.
20. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, et al. (2007) Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16: 763-768.
21. Key TJ, Appleby PN, Reeves GK, Roddam AW, (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. The lancet oncology 11: 530-542.
22. Firth SM, Baxter RC, (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews 23: 824-854.
23. Oh Y, Muller HL, Pham H, Rosenfeld RG, (1993) Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. The Journal of biological chemistry 268: 26045-26048.
24. Rajah R, Valentinis B, Cohen P, (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. The Journal of biological chemistry 272: 12181-12188.
25. Mohan S, Baylink DJ, (2002) IGF-binding proteins are multifunctional and act via IGF-dependent and-independent mechanisms. The Journal of endocrinology 175: 19-31.
26. Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, et al. (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-related cancer 13: 593-605.
27. Tomii K, Tsukuda K, Toyooka S, Dote H, Hanafusa T, et al. (2007) Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. International journal of cancer Journal international du cancer 120: 566-573.
28. Grkovic S, O'Reilly VC, Han S, Hong M, Baxter RC, et al. (2012) IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene 32(19): 2412-2420.
29. Mehta HH, Gao Q, Galet C, Paharkova V, Wan J, et al. (2011) IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer research 71: 5154-5163.
30. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, et al. (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49.
31. Hampton OA, Den Hollander P, Miller CA, Delgado DA, Li J, et al. (2009) A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome research 19: 167-177.
32. Schoenfelder S, Sexton T, Chakalova L, Cope NF, Horton A, et al. (2010) Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nature genetics 42: 53-61.
33. Kalhor R, Tjong H, Jayathilaka N, Alber F, Chen L, (2012) Genome architectures revealed by tethered chromosome conformation capture and population-based modeling. Nature biotechnology 30: 90-98.
34. Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, et al. (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proceedings of the National Academy of Sciences of the United States of America 108: 4364-4369.
35. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD, (2007) FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome research 17: 877-885.
36. Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, et al. (2012) Oncogene-mediated alterations in chromatin conformation. Proceedings of the National Academy of Sciences of the United States of America.
37. Lin SY, Makino K, Xia W, Matin A, Wen Y, et al. (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature cell biology 3: 802-808.
38. Salomon DS, Brandt R, Ciardiello F, Normanno N, (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Critical reviews in oncology/hematology 19: 183-232.
39. Cancer Genome Atlas Network, (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
40. Buck E, Eyzaguirre A, Rosenfeld-Franklin M, Thomson S, Mulvihill M, et al. (2008) Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer research 68: 8322-8332.
41. Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, et al. (2004) Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. The Journal of clinical endocrinology and metabolism 89: 1950-1956.
42. Takaoka M, Harada H, Andl CD, Oyama K, Naomoto Y, et al. (2004) Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer research 64: 7711-7723.
43. Jackson DA, Hassan AB, Errington RJ, Cook PR, (1993) Visualization of focal sites of transcription within human nuclei. The EMBO journal 12: 1059-1065.
44. Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, et al. (2012) Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148: 84-98.
45. Zhang Y, McCord RP, Ho YJ, Lajoie BR, Hildebrand DG, et al. (2012) Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148: 908-921.
46. Neves H, Ramos C, da Silva MG, Parreira A, Parreira L, (1999) The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93: 1197-1207.
47. Rocha PP, Micsinai M, Kim JR, Hewitt SL, Souza PP, et al. (2012) Close Proximity to Igh Is a Contributing Factor to AID-Mediated Translocations. Molecular cell 47(6): 873-885.
48. Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T, (2003) Spatial proximity of translocation-prone gene loci in human lymphomas. Nature genetics 34: 287-291.
49. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
50. Mani RS, Tomlins SA, Callahan K, Ghosh A, Nyati MK, et al. (2009) Induced chromosomal proximity and gene fusions in prostate cancer. Science 326: 1230.
51. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, et al. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proceedings of the National Academy of Sciences of the United States of America 91: 2156-2160.
52. Tanner MM, Tirkkonen M, Kallioniemi A, Holli K, Collins C, et al. (1995) Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clinical cancer research: an official journal of the American Association for Cancer Research 1: 1455-1461.
53. Qi C, Zhu YT, Chang J, Yeldandi AV, Rao MS, et al. (2005) Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2. Biochemical and biophysical research communications 328: 393-398.
54. Kuo PC, Tsao YP, Chang HW, Chen PH, Huang CW, et al. (2009) Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor. Cancer research 69: 8877-8885.
55. Gururaj AE, Holm C, Landberg G, Kumar R, (2006) Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell cycle 5: 1407-1410.
56. Ruan Y, Ooi HS, Choo SW, Chiu KP, Zhao XD, et al. (2007) Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome research 17: 828-838.
57. Barlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, et al. (2002) Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes, chromosomes & cancer 35: 311-317.
58. Soutoglou E, Misteli T, (2007) Mobility and immobility of chromatin in transcription and genome stability. Current Opinion in Genetics & Development 17: 435-442.
59. Ryba T, Hiratani I, Lu J, Itoh M, Kulik M, et al. (2010) Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. Genome research 20: 761-770.
60. Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt KR, et al. (2008) Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proceedings of the National Academy of Sciences of the United States of America 105: 19199-19204.
61. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T, (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193.
62. Gheldof N, Leleu M, Noordermeer D, Rougemont J, Reymond A, (2012) Detecting long-range chromatin interactions using the chromosome conformation capture sequencing (4C-seq) method. Methods in molecular biology 786: 211-225.
63. Splinter E, de Wit E, van de Werken HJ, Klous P, de Laat W, (2012) Determining long-range chromatin interactions for selected genomic sites using 4C-seq technology: From fixation to computation. Methods 58(3): 221-230.
64. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology 3: RESEARCH0034.
65. Zhao S, Fernald RD, (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. Journal of computational biology: a journal of computational molecular cell biology 12: 1047-1064.
66. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research 29: e45.